title: Hepatotoxicity due to lysine salt of bendazac.
abstract: BACKGROUND
  The lysine salt of bendazac is a non-steroidal anti-inflammatory agent, and it is marketed exclusively for the treatment of cataracts. We report two cases of possible hepatotoxicity due to the use of bendazac lysine.
  
  
  METHODS
  Laboratory tests, serologic tests, abdominal sonography and scan were performed to study liver disease.
  
  
  RESULTS
  Reversible increases of the hepatic enzymes were found in both cases. Anemia was also found in one of the cases (case 1).
  
  
  CONCLUSIONS
  Abnormal liver test results could be related to a possible liver injury attributed to the use of bendazac lysine.
authors.affiliation: Gastroenterology Dept. Infanta Cristina University Hospital, University of Extremadura, Badajoz, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Alcalde
authors.forename: M
authors.initials: M
authors.lastname: Garcia-Diaz
authors.forename: F
authors.initials: F
authors.lastname: Najarro
authors.forename: M S
authors.initials: MS
authors.lastname: Donoso
authors.forename: L
authors.initials: L
authors.lastname: Cebria
authors.forename: J M
authors.initials: JM
authors.lastname: Pascasio
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D002386:Cataract / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007191:Indazoles / Q000009:adverse effects* / Q000627:therapeutic use; D008111:Liver Function Tests
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007191:Indazoles; C036067:bendazac lysine